What’s the best approach for investments in AI-based implementations? At this year's Frontiers Health conference, Intouch experts will discuss the 'what' and 'how'; we'll also hear a case study on creating an augmented-reality tool to help oncology HCPs empathize with patients undergoing chemotherapy, developed together with Athenex Oncology.
AI isn't new, but that doesn't mean it's easy to implement. To help build understanding -- about creating AI systems & the benefits pharma can reap when using them -- Intouch VP of innovation, Abid Rahman will lead a masterclass during the upcoming AHIMA2020 virtual conference.
Ninety-five percent of rare diseases lack an FDA-approved treatment. But this is where machine learning and artificial intelligence can help. Intouch and PharmaPhorum take a look at what's possible with this exciting tech.
Two of Intouch's innovation experts attended CES 2020 earlier this month and brought back highlights from the conference, including scary-real-looking, AI-powered artificial humans, advances in personal health tech and more.
As artificial intelligence (AI) continues to make daily news - even the White House has weighed in - it's more than safe to say that this tech is not a flash in the pan that will soon fizzle out. It's here to stay. But what does AI in everyday life
Intouch VP of innovation Abid Rahman worked in collaboration with Jan van den Burg, VP of commercial strategy at Veeva, to break down what these technologies are and how to integrate data analysis, predictive modeling and automation into your business to improve customer experiences.
There’s never been a better time to put the amazing capabilities of artificial intelligence to work in pharma marketing. Intouch VP of Innovation, Abid Rahman talks about the what, how and why - read on to learn more.
Whether it's being paired with an MRI scanner to cut scan time, defeating the best gamers at strategy, or helping investors make decisions, artificial intelligence (AI) is making headlines daily. But where does pharma fit in? The buzz around AI can often be overwhelming, with little indication of how to
From the massive amounts of useful customer-generated data to the exponential growth in computing power to cheaper, faster data storage and the development of deep neural networks, artificial intelligence (AI) is getting easier and easier to implement. But how does AI rank in the minds of pharmaceutical executives?
Justin Chase, Intouch EVP of innovation and media, recently sat down to talk with MM&M senior editor Larry Dobrow about the evolution of Intouch, how it has embraced innovation from day one, his own arrival at the agency to build the innovation practice, and how Intouch has applied its AI